Recombinant anti-EGFR monoclonal antibody
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant anti-EGFR monoclonal antibody, covering 2015-04-09 to 2018-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC [Phase 2]